Featured Research

from universities, journals, and other organizations

People with impaired glucose tolerance can show cognitive dysfunction

Date:
July 16, 2013
Source:
Institute of Food Technologists (IFT)
Summary:
People with impaired glucose tolerance—the precursor to Type 2 diabetes—often show impaired cognitive function that may be alleviated through a diet designed specifically for their condition, according to new research.

People with impaired glucose tolerance -- the precursor to Type 2 diabetes -- often show impaired cognitive function that may be alleviated through a diet designed specifically for their condition, according to a panel discussion at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Expo®.

Impaired glucose tolerance is a pre-diabetic state of hyperglycemia that is associated with insulin resistance and a higher risk of cardiovascular disease. It can precede Type 2 diabetes by several years, and some lifestyle changes, such as getting to a normal weight and increasing exercise, can help pre-diabetic people avoid that progression completely.

Louise Dye, Ph.D., professor of nutrition and behavior in the Human Appetite Research Unit at the Institute of Psychological Sciences, University of Leeds, presented research in which she examined 31 previous studies regarding cognitive performance under various dietary conditions. She found that the impaired glucose tolerance group showed difficulties in 12 of 27 cognitive test outcomes, including word recognition, visual verbal learning test, visual spatial learning test, psychomotor test and Corsi block-tapping. The impaired glucose tolerance group was made up of all middle-aged women who appeared to be in general good health.

"There was significant impairment in those women who were impaired glucose tolerant," Dye said. "To me, that feels like a ticking time bomb. We need to use food -- the diet and food industry -- to help us shift these people back from impaired glucose tolerance. By the time they get to Type 2 diabetes, the impairments are much more evident."

She pointed to a 2009 Japanese study of 129 people in their 80s, 55 of whom had impaired glucose tolerance or Type 2 diabetes. All the subjects in the study consumed more than 30 grams of dietary fiber per day and exercised two to four times per week over a two-year period. Within that timeframe, the 36 people with impaired glucose tolerance showed improvements in delayed recall and block design tests. The Type 2 diabetes group showed improvement in dementia, delayed recall and their mental state.

"That tells us something about how improving glucose regulation through dietary fiber and exercise could improve cognitive functions," Dye said.

She called on the food industry to continue researching the best products for consumers with glucose tolerance issues, such as those foods with increased fiber and those with limited glycemic impact.

Another panelist, Nicolas Bordenave, Ph.D., associate principal scientist in the analytical department of PepsiCo Global R&D, said a key aspect to consider in glucose management is satiety. He said two proven avenues for doing that are a shift toward slowly digestible starch and resistant starch in foods and enhanced viscosity of food through digestion. However, he noted that a challenge for food manufacturers is to create foods with these characteristics that taste appealing to consumers, another challenge being the application of new discoveries on the mechanisms of satiety into food products.

“From the consumer standpoint there is still a lot to understand,” he said. “Right now, people think of glucose management in terms of satiety. They are not aware yet of the effect of glucose delivery on their mental performance, for example, and of all the possible ways to achieve proper glucose management. It’s really about consumer education.”


Story Source:

The above story is based on materials provided by Institute of Food Technologists (IFT). Note: Materials may be edited for content and length.


Cite This Page:

Institute of Food Technologists (IFT). "People with impaired glucose tolerance can show cognitive dysfunction." ScienceDaily. ScienceDaily, 16 July 2013. <www.sciencedaily.com/releases/2013/07/130716115721.htm>.
Institute of Food Technologists (IFT). (2013, July 16). People with impaired glucose tolerance can show cognitive dysfunction. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2013/07/130716115721.htm
Institute of Food Technologists (IFT). "People with impaired glucose tolerance can show cognitive dysfunction." ScienceDaily. www.sciencedaily.com/releases/2013/07/130716115721.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins